title: Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance.
authors.forename: V
authors.initials: V
authors.lastname: Grossmann
authors.forename: A
authors.initials: A
authors.lastname: Kohlmann
authors.forename: C
authors.initials: C
authors.lastname: Eder
authors.forename: C
authors.initials: C
authors.lastname: Haferlach
authors.forename: W
authors.initials: W
authors.lastname: Kern
authors.forename: N C P
authors.initials: NC
authors.lastname: Cross
authors.forename: T
authors.initials: T
authors.lastname: Haferlach
authors.forename: S
authors.initials: S
authors.lastname: Schnittger
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000235:genetics*; D049308:Dioxygenases; D000071221:Enhancer of Zeste Homolog 2 Protein; D020869:Gene Expression Profiling; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D063151:Polycomb Repressive Complex 2; D011379:Prognosis; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D015996:Survival Rate; D014157:Transcription Factors / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; D004268:DNA-Binding Proteins; D011518:Proto-Oncogene Proteins; D014157:Transcription Factors; D049308:Dioxygenases; C541081:TET2 protein, human; C498409:EZH2 protein, human; D000071221:Enhancer of Zeste Homolog 2 Protein; D063151:Polycomb Repressive Complex 2